Morningstar has issued a BUY recommendation on Sanofi SA, with an upgraded fair value target of $63 from $61 due to consistent revenue growth and strong performance in immunology and vaccine divisi
SMC Global Securities has given BUY call for FMCG company Dabur India, pharmaceutical major Sanofi India and PI Industries.
